SCHEMBL680489

SCHEMBL680489

Cc1cccc(C)c1Oc1ccc(C(=O)NS(C)(=O)=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN3A Q9NY46 1/20 0.45
SCN9A Q15858 7/20 0.45
LPAR1 Q92633 2/20 0.45
LPAR5 Q9H1C0 2/20 0.45
SCN2B O60939 4/20 0.45
SCN1A P35498 4/20 0.45
SCN1B Q07699 4/20 0.45
SCN5A Q14524 3/20 0.45
P4HTM Q9NXG6 2/20 0.44
BCL2L1 Q07817 2/20 0.44
MCL1 Q07820 2/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MMP13 P45452 1/20 0.43
CACNA1H O95180 1/20 0.41
CACNA1B Q00975 1/20 0.41
PTPN1 P18031 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680758 0.85 ALDH1A1 (0.51) SCN3ASCN9ASCN2BSCN1ASCN1B
SCHEMBL679956 0.84 MAPK14 (0.55) SCN3ASCN9ALPAR1LPAR5SCN2B
SCHEMBL680561 0.81 MMP13 (0.65) SCN3ASCN9ABCL2L1MCL1HPGD
SCHEMBL680466 0.80 EZH2 (0.54) SCN9ASCN2BSCN1ASCN1BSCN5A
SCHEMBL679703 0.79 SCN9A (0.49) SCN3ASCN9ASCN2BSCN1ASCN1B
SCHEMBL680791 0.78 CA1 (0.61) BCL2L1MCL1HPGDTSHRHTT
SCHEMBL680289 0.78 MCL1 (0.70) SCN3ASCN9ABCL2L1MCL1HPGD
SCHEMBL680496 0.78 MMP13 (0.51) SCN3ASCN9AP4HTMBCL2L1MCL1
SCHEMBL28377302 0.77 LPAR1 (0.54) LPAR1LPAR5HPGD
SCHEMBL680286 0.77 PGR (0.60) SCN9ASCN2BSCN1ASCN1BSCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 EP disclosed
US-20120010207-A1 Chemical Compounds PFIZER LIMITED (GB) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010207-A1 Chemical Compounds SCN1A, SCN1B, SCN7A SCN3A 8/4885SCN9A 13/4885LPAR1 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.